TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs10788160
log Bayes Factor = 19.1751
Chromosome 10   position 123,033,549  (GRCh37) Explore rs10788160 on Ensembl!
Variant rs10788160 is listed in the   GWAS Catalog   ⇪
Variant rs10788160 is part of Cluster X0325

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
N40 Hyperplasia of prostate
1.000 0.000 0.000
R33 Retention of urine
1.000 0.000 0.000
R79.8 Other specified abnormal findings of blood chemistry
0.995 0.005 0.000
N32 Other disorders of bladder
0.994 0.006 0.000
R30-R39 Symptoms and signs involving the urinary system
0.993 0.007 0.000
N32.8 Other specified disorders of bladder
0.993 0.007 0.000
N32.3 Diverticulum of bladder
0.992 0.008 0.000
R79 Other abnormal findings of blood chemistry
0.988 0.012 0.000
R18 Ascites
0.987 0.013 0.000
N32.0 Bladder-neck obstruction
0.972 0.028 0.000
R70-R79 Abnormal findings on examination of blood, without diagnosis
0.971 0.029 0.000
Chapter XVIII Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
0.971 0.029 0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
0.955 0.045 0.000
R31 Unspecified haematuria
0.955 0.045 0.000
Chapter II Neoplasms
0.945 0.055 0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma
0.942 0.058 0.000
C76-C80 Malignant neoplasms of ill-defined, secondary and unspecified sites
0.940 0.060 0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma
0.940 0.060 0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified
0.934 0.066 0.000
C78 Secondary malignant neoplasm of respiratory and digestive organs
0.934 0.066 0.000
C78.6 Secondary malignant neoplasm of retroperitoneum and peritoneum
0.931 0.069 0.000
R79.9 Abnormal finding of blood chemistry, unspecified
0.921 0.079 0.000
C15-C26 Malignant neoplasms of digestive organs
0.895 0.105 0.000
C85.1 B-cell lymphoma, unspecified
0.886 0.114 0.000
R90-R94 Abnormal findings on diagnostic imaging and in function studies, without diagnosis
0.885 0.115 0.000
R80-R82 Abnormal findings on examination of urine, without diagnosis
0.883 0.117 0.000
C78.0 Secondary malignant neoplasm of lung
0.879 0.121 0.000
R83-R89 Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis
0.878 0.122 0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type
0.877 0.123 0.000
C15 Malignant neoplasm of oesophagus
0.876 0.124 0.000
C45-C49 Malignant neoplasms of mesothelial and soft tissue
0.868 0.132 0.000
C15.9 Oesophagus, unspecified
0.864 0.136 0.000
D00-D09 In situ neoplasms
0.861 0.139 0.000
R94 Abnormal results of function studies
0.859 0.141 0.000
R94.5 Abnormal results of liver function studies
0.851 0.149 0.000
R86 Abnormal findings in specimens from male genital organs
0.835 0.165 0.000
C45 Mesothelioma
0.829 0.171 0.000
C40-C41 Malignant neoplasms of bone and articular cartilage
0.826 0.174 0.000
C16 Malignant neoplasm of stomach
0.819 0.181 0.000
R80 Isolated proteinuria
0.818 0.182 0.000
R92 Abnormal findings on diagnostic imaging of breast
0.814 0.186 0.000
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx
0.813 0.187 0.000
R36 Urethral discharge
0.811 0.189 0.000
N32.2 Vesical fistula, not elsewhere classified
0.810 0.189 0.000
C77 Secondary and unspecified malignant neoplasm of lymph nodes
0.805 0.195 0.000
C91 Lymphoid leukaemia
0.804 0.196 0.000
C84 Peripheral and cutaneous T-cell lymphomas
0.796 0.204 0.000
C77.5 Intrapelvic lymph nodes
0.789 0.211 0.000
C50-C50 Malignant neoplasm of breast
0.788 0.212 0.000
D04 Carcinoma in situ of skin
0.787 0.213 0.000
N30-N39 Other diseases of urinary system
0.784 0.216 0.000
C83 Diffuse non-Hodgkin's lymphoma
0.777 0.223 0.000
C86 Other specified types of T/NK-cell lymphoma
0.775 0.225 0.000
C25 Malignant neoplasm of pancreas
0.771 0.229 0.000
D07 Carcinoma in situ of other and unspecified genital organs
0.767 0.233 0.000
C79 Secondary malignant neoplasm of other sites
0.766 0.234 0.000
D37-D48 Neoplasms of uncertain or unknown behaviour
0.759 0.241 0.000
C15.0 Cervical part of oesophagus
0.758 0.242 0.000
C92 Myeloid leukaemia
0.756 0.244 0.000
D00 Carcinoma in situ of oral cavity, oesophagus and stomach
0.756 0.244 0.000
C95 Leukaemia of unspecified cell type
0.753 0.247 0.000
C83.3 Large cell (diffuse)
0.744 0.256 0.000
N32.1 Vesicointestinal fistula
0.741 0.259 0.000
R30 Pain associated with micturition
0.739 0.261 0.000
C41 Malignant neoplasm of bone and articular cartilage of other and unspecified sites
0.739 0.261 0.000
D04.5 Skin of trunk
0.734 0.266 0.000
C16.0 Cardia
0.731 0.269 0.000
N30 Cystitis
0.729 0.271 0.000
C25.0 Head of pancreas
0.727 0.273 0.000
C90 Multiple myeloma and malignant plasma cell neoplasms
0.727 0.273 0.000
R81 Glycosuria
0.726 0.274 0.000
R34 Anuria and oliguria
0.725 0.275 0.000
C02 Malignant neoplasm of other and unspecified parts of tongue
0.724 0.276 0.000
C77.2 Intra-abdominal lymph nodes
0.724 0.276 0.000
C78.3 Secondary malignant neoplasm of other and unspecified respiratory organs
0.721 0.279 0.000
C78.7 Secondary malignant neoplasm of liver
0.720 0.280 0.000
R94.6 Abnormal results of thyroid function studies
0.719 0.281 0.000
C85.7 Other specified types of non-Hodgkin's lymphoma
0.718 0.282 0.000
C80 Malignant neoplasm without specification of site
0.718 0.282 0.000
N32.4 Rupture of bladder, nontraumatic
0.713 0.287 0.000
R86.9 Unspecified abnormal finding
0.710 0.290 0.000
N40-N51 Diseases of male genital organs
0.708 0.292 0.000
N36 Other disorders of urethra
0.706 0.294 0.000
C20 Malignant neoplasm of rectum
0.706 0.294 0.000
R86.0 Abnormal level of enzymes
0.706 0.294 0.000
C45.7 Mesothelioma of other sites
0.705 0.295 0.000
N30.2 Other chronic cystitis
0.704 0.296 0.000
C82.4 Follicular lymphoma grade IIIb
0.704 0.296 0.000
D40 Neoplasm of uncertain or unknown behaviour of male genital organs
0.703 0.297 0.000
R86.5 Abnormal microbiological findings
0.701 0.299 0.000
C45.9 Mesothelioma, unspecified
0.701 0.299 0.000
R94.7 Abnormal results of other endocrine function studies
0.701 0.299 0.000
C82.0 Small cleaved cell, follicular
0.700 0.300 0.000
C45.1 Mesothelioma of peritoneum
0.697 0.303 0.000
R75 Laboratory evidence of human immunodeficiency virus [HIV]
0.696 0.304 0.000
C78.5 Secondary malignant neoplasm of large intestine and rectum
0.696 0.304 0.000
R95-R99 Ill-defined and unknown causes of mortality
0.696 0.304 0.000
D46 Myelodysplastic syndromes
0.695 0.305 0.000
R83 Abnormal findings in cerebrospinal fluid
0.694 0.306 0.000
C07 Malignant neoplasm of parotid gland
0.694 0.306 0.000
R39 Other symptoms and signs involving the urinary system
0.693 0.307 0.000
R78 Findings of drugs and other substances, not normally found in blood
0.692 0.308 0.000
C24 Malignant neoplasm of other and unspecified parts of biliary tract
0.691 0.309 0.000
C14 Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx
0.691 0.309 0.000
R86.6 Abnormal cytological findings
0.688 0.312 0.000
R25-R29 Symptoms and signs involving the nervous and musculoskeletal systems
0.687 0.313 0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.685 0.315 0.000
C94 Other leukaemias of specified cell type
0.685 0.315 0.000
D04.9 Skin, unspecified
0.684 0.316 0.000
C16.9 Stomach, unspecified
0.683 0.317 0.000
R30.0 Dysuria
0.682 0.318 0.000
R84 Abnormal findings in specimens from respiratory organs and thorax
0.678 0.322 0.000
C91.4 Hairy-cell leukaemia
0.676 0.324 0.000
C82.6 Cutaneous follicle centre lymphoma
0.676 0.324 0.000
C82.5 Diffuse follicle centre lymphoma
0.676 0.324 0.000
C50 Malignant neoplasm of breast
0.675 0.325 0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma
0.674 0.326 0.000
C85.0 Lymphosarcoma
0.674 0.326 0.000
R35 Polyuria
0.673 0.327 0.000
C50.3 Lower-inner quadrant of breast
0.673 0.327 0.000
D07.1 Vulva
0.671 0.329 0.000
C82.3 Follicular lymphoma grade IIIa
0.670 0.330 0.000
N30.0 Acute cystitis
0.667 0.333 0.000
C79.0 Secondary malignant neoplasm of kidney and renal pelvis
0.665 0.335 0.000
C84.5 Other and unspecified T-cell lymphomas
0.665 0.335 0.000
C82.1 Mixed small cleaved and large cell, follicular
0.665 0.335 0.000
R71 Abnormality of red blood cells
0.663 0.337 0.000
C77.8 Lymph nodes of multiple regions
0.663 0.337 0.000
C91.1 Chronic lymphocytic leukaemia
0.661 0.339 0.000
D07.4 Penis
0.659 0.341 0.000
C80.0 Malignant neoplasm, primary site unknown, so stated
0.659 0.341 0.000
D00.1 Oesophagus
0.658 0.342 0.000
C45.0 Mesothelioma of pleura
0.657 0.343 0.000
Chapter XIV Diseases of the genitourinary system
0.657 0.343 0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma
0.654 0.346 0.000
C79.9 Secondary malignant neoplasm, unspecified site
0.654 0.346 0.000
C82.2 Large cell, follicular
0.650 0.350 0.000
C15.3 Upper third of oesophagus
0.649 0.351 0.000
D09 Carcinoma in situ of other and unspecified sites
0.649 0.351 0.000
C78.1 Secondary malignant neoplasm of mediastinum
0.647 0.353 0.000
R39.1 Other difficulties with micturition
0.647 0.353 0.000
C86.5 Angioimmunoblastic T-cell lymphoma
0.645 0.354 0.000
D40.0 Prostate
0.644 0.356 0.000
C16.2 Body of stomach
0.643 0.357 0.000
R86.7 Abnormal histological findings
0.643 0.357 0.000
C92.5 Acute myelomonocytic leukaemia
0.642 0.358 0.000
D02 Carcinoma in situ of middle ear and respiratory system
0.641 0.359 0.000
C25.1 Body of pancreas
0.641 0.359 0.000
C93 Monocytic leukaemia
0.640 0.360 0.000
R89 Abnormal findings in specimens from other organs, systems and tissues
0.640 0.360 0.000
D04.6 Skin of upper limb, including shoulder
0.640 0.360 0.000
C22 Malignant neoplasm of liver and intrahepatic bile ducts
0.639 0.361 0.000
R90 Abnormal findings on diagnostic imaging of central nervous system
0.638 0.362 0.000
R72 Abnormality of white blood cells, not elsewhere classified
0.637 0.362 0.000
N34 Urethritis and urethral syndrome
0.635 0.365 0.000
C17 Malignant neoplasm of small intestine
0.633 0.367 0.000
R26 Abnormalities of gait and mobility
0.633 0.367 0.000
D41 Neoplasm of uncertain or unknown behaviour of urinary organs
0.631 0.369 0.000
R94.2 Abnormal results of pulmonary function studies
0.629 0.371 0.000
C15.8 Overlapping lesion of oesophagus
0.628 0.372 0.000
C15.2 Abdominal part of oesophagus
0.628 0.372 0.000
C15.1 Thoracic part of oesophagus
0.628 0.372 0.000
R77 Other abnormalities of plasma proteins
0.626 0.373 0.000
C00 Malignant neoplasm of lip
0.626 0.374 0.000
R79.0 Abnormal level of blood mineral
0.625 0.375 0.000
C84.4 Peripheral T-cell lymphoma
0.624 0.376 0.000
C47 Malignant neoplasm of peripheral nerves and autonomic nervous system
0.622 0.377 0.000
C46 Kaposi's sarcoma
0.622 0.377 0.000
R70 Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity
0.621 0.379 0.000
C91.0 Acute lymphoblastic leukaemia
0.621 0.379 0.000
# Top node
0.620 0.380 0.000
R74 Abnormal serum enzyme levels
0.619 0.381 0.000
C48 Malignant neoplasm of retroperitoneum and peritoneum
0.618 0.382 0.000
R94.1 Abnormal results of function studies of peripheral nervous system and special senses
0.616 0.384 0.000
R76 Other abnormal immunological findings in serum
0.615 0.385 0.000
C16.6 Greater curvature of stomach, unspecified
0.615 0.385 0.000
C41.0 Bones of skull and face
0.611 0.389 0.000
C10 Malignant neoplasm of oropharynx
0.610 0.390 0.000
C16.1 Fundus of stomach
0.609 0.391 0.000
C79.1 Secondary malignant neoplasm of bladder and other and unspecified urinary organs
0.607 0.393 0.000
N36.0 Urethral fistula
0.607 0.393 0.000
C41.1 Mandible
0.607 0.393 0.000
C03 Malignant neoplasm of gum
0.606 0.394 0.000
C95.1 Chronic leukaemia of unspecified cell type
0.604 0.396 0.000
C90.3 Solitary plasmacytoma
0.604 0.396 0.000
C02.1 Border of tongue
0.603 0.397 0.000
C14.0 Pharynx, unspecified
0.603 0.397 0.000
D43 Neoplasm of uncertain or unknown behaviour of brain and central nervous system
0.603 0.397 0.000
D03 Melanoma in situ
0.602 0.398 0.000
C06 Malignant neoplasm of other and unspecified parts of mouth
0.602 0.398 0.000
N42 Other disorders of prostate
0.601 0.399 0.000
D07.2 Vagina
0.601 0.399 0.000
R86.4 Abnormal immunological findings
0.599 0.401 0.000
R86.3 Abnormal level of substances chiefly nonmedicinal as to source
0.599 0.401 0.000
R86.2 Abnormal level of other drugs, medicaments and biological substances
0.599 0.401 0.000
R86.1 Abnormal level of hormones
0.599 0.401 0.000
C40 Malignant neoplasm of bone and articular cartilage of limbs
0.599 0.401 0.000
C92.9 Myeloid leukaemia, unspecified
0.595 0.405 0.000
C45.2 Mesothelioma of pericardium
0.594 0.405 0.000
C12 Malignant neoplasm of pyriform sinus
0.594 0.406 0.000
C50.4 Upper-outer quadrant of breast
0.594 0.406 0.000
C41.2 Vertebral column
0.593 0.407 0.000
D04.1 Skin of eyelid, including canthus
0.593 0.407 0.000
R10-R19 Symptoms and signs involving the digestive system and abdomen
0.593 0.407 0.000
C42 hematopoietic and reticuloendothelial systems (ICD-O-3 specific)
0.592 0.407 0.000
D46.7 Other myelodysplastic syndromes
0.592 0.408 0.000
R26.0 Ataxic gait
0.592 0.408 0.000
D00.0 Lip, oral cavity and pharynx
0.590 0.410 0.000
C16.8 Overlapping lesion of stomach
0.587 0.412 0.000
D45 Polycythaemia vera
0.585 0.415 0.000
D46.2 Refractory anaemia with excess of blasts
0.584 0.416 0.000
D01 Carcinoma in situ of other and unspecified digestive organs
0.583 0.417 0.000
C13 Malignant neoplasm of hypopharynx
0.583 0.417 0.000
N30.1 Interstitial cystitis (chronic)
0.581 0.419 0.000
N43 Hydrocele and spermatocele
0.580 0.420 0.000
C91.8 Mature B-cell leukaemia Burkitt-type
0.577 0.423 0.000
C91.7 Other lymphoid leukaemia
0.577 0.423 0.000
C91.6 Prolymphocytic leukaemia of T-cell type
0.577 0.423 0.000
C91.3 Prolymphocytic leukaemia
0.577 0.423 0.000
C91.2 Subacute lymphocytic leukaemia
0.577 0.423 0.000
R85 Abnormal findings in specimens from digestive organs and abdominal cavity
0.576 0.424 0.000
C02.9 Tongue, unspecified
0.574 0.426 0.000
D04.4 Skin of scalp and neck
0.571 0.429 0.000
C84.9 Mature T/NK-cell lymphoma, unspecified
0.571 0.429 0.000
C84.8 Cutaneous T-cell lymphoma, unspecified
0.571 0.429 0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative
0.571 0.429 0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive
0.571 0.429 0.000
C84.3 Lymphoepithelioid lymphoma
0.571 0.429 0.000
C84.2 T-zone lymphoma
0.571 0.429 0.000
C84.1 Sezary's diease
0.571 0.429 0.000
C79.4 Secondary malignant neoplasm of other and unspecified parts of nervous system
0.569 0.431 0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.568 0.432 0.000
C26 Malignant neoplasm of other and ill-defined digestive organs
0.567 0.433 0.000
C90.2 Plasmacytoma, extramedullary
0.566 0.434 0.000
D40.1 Testis
0.566 0.434 0.000
D04.8 Skin of other sites
0.564 0.436 0.000
D04.0 Skin of lip
0.564 0.436 0.000
N37 Urethral disorders in diseases classified elsewhere
0.562 0.437 0.000
N33 Bladder disorders in diseases classified elsewhere
0.562 0.437 0.000
C02.4 Lingual tonsil
0.562 0.438 0.000
R83.8 Other abnormal findings
0.562 0.438 0.000
C97-C97 Malignant neoplasms of independent (primary) multiple sites
0.562 0.438 0.000
R94.0 Abnormal results of function studies of central nervous system
0.562 0.438 0.000
N45 Orchitis and epididymitis
0.562 0.438 0.000
C79.5 Secondary malignant neoplasm of bone and bone marrow
0.561 0.439 0.000
D46.9 Myelodysplastic syndrome, unspecified
0.561 0.439 0.000
Chapter XX External causes of morbidity and mortality
0.560 0.440 0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use
0.560 0.440 0.000
N36.8 Other specified disorders of urethra
0.559 0.441 0.000
Y42.7 Androgens and anabolic congeners
0.558 0.442 0.000
C83.6 Undifferentiated (diffuse)
0.557 0.443 0.000
C83.5 Lymphoblastic (diffuse)
0.557 0.443 0.000
C83.4 Immunoblastic (diffuse)
0.557 0.443 0.000
C83.2 Mixed small and large cell (diffuse)
0.557 0.443 0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations
0.555 0.444 0.000
C86.4 Blastic NK-cell lymphoma
0.555 0.444 0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma
0.555 0.444 0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma
0.555 0.444 0.000
C86.1 Hepatosplenic T-cell lymphoma
0.555 0.444 0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type
0.555 0.444 0.000
C92.0 Acute myeloid leukaemia
0.555 0.445 0.000
D41.2 Ureter
0.555 0.445 0.000
C04 Malignant neoplasm of floor of mouth
0.554 0.446 0.000
N42.9 Disorder of prostate, unspecified
0.554 0.446 0.000
C25.8 Overlapping lesion of pancreas
0.553 0.447 0.000
C25.4 Endocrine pancreas
0.553 0.447 0.000
C79.6 Secondary malignant neoplasm of ovary
0.552 0.448 0.000
C88 Malignant immunoproliferative diseases
0.551 0.448 0.000
R26.2 Difficulty in walking, not elsewhere classified
0.551 0.449 0.000
C90.1 Plasma cell leukaemia
0.551 0.449 0.000
D07.6 Other and unspecified male genital organs
0.550 0.450 0.000
D07.3 Other and unspecified female genital organs
0.550 0.450 0.000
D07.0 Endometrium
0.550 0.450 0.000
N30.4 Irradiation cystitis
0.549 0.451 0.000
C23 Malignant neoplasm of gallbladder
0.549 0.451 0.000
C16.5 Lesser curvature of stomach, unspecified
0.548 0.451 0.000
C92.4 Acute promyelocytic leukaemia
0.547 0.452 0.000
C79.7 Secondary malignant neoplasm of adrenal gland
0.547 0.453 0.000
C95.9 Leukaemia, unspecified
0.547 0.453 0.000
C24.0 Extrahepatic bile duct
0.545 0.455 0.000
D42 Neoplasm of uncertain or unknown behaviour of meninges
0.544 0.456 0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia
0.542 0.457 0.000
C92.7 Other myeloid leukaemia
0.542 0.457 0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality
0.542 0.457 0.000
C92.3 Myeloid sarcoma
0.542 0.457 0.000
C92.2 Subacute myeloid leukaemia
0.542 0.457 0.000
D00.2 Stomach
0.542 0.458 0.000
C84.0 Mycosis fungoides
0.540 0.459 0.000
C95.7 Other leukaemia of unspecified cell type
0.540 0.460 0.000
C95.2 Subacute leukaemia of unspecified cell type
0.540 0.460 0.000
C95.0 Acute leukaemia of unspecified cell type
0.540 0.460 0.000
C02.2 Ventral surface of tongue
0.540 0.460 0.000
Chapter XXII Codes for special purposes
0.539 0.461 0.000
C16.4 Pylorus
0.539 0.461 0.000
N36.9 Urethral disorder, unspecified
0.537 0.463 0.000
C16.3 Pyloric antrum
0.536 0.464 0.000
C50.1 Central portion of breast
0.536 0.464 0.000
R94.4 Abnormal results of kidney function studies
0.536 0.464 0.000
Y57 Other and unspecified drugs and medicaments
0.533 0.467 0.000
N36.1 Urethral diverticulum
0.532 0.468 0.000
C41.8 Overlapping lesion of bone and articular cartilage
0.530 0.470 0.000
C41.3 Ribs, sternum and clavicle
0.530 0.470 0.000
D04.7 Skin of lower limb, including hip
0.530 0.470 0.000
N36.2 Urethral caruncle
0.530 0.470 0.000
C49 Malignant neoplasm of other connective and soft tissue
0.530 0.470 0.000
C41.9 Bone and articular cartilage, unspecified
0.529 0.471 0.000
C22.9 Liver, unspecified
0.528 0.472 0.000
C91.5 Adult T-cell leukaemia
0.526 0.473 0.000
C08 Malignant neoplasm of other and unspecified major salivary glands
0.526 0.474 0.000
C51-C58 Malignant neoplasms of female genital organs
0.525 0.475 0.000
D03.6 Melanoma in situ of upper limb, including shoulder
0.524 0.476 0.000
R84.5 Abnormal microbiological findings
0.524 0.476 0.000
N51 Disorders of male genital organs in diseases classified elsewhere
0.523 0.476 0.000
C17.0 Duodenum
0.520 0.480 0.000
C02.8 Overlapping lesion of tongue
0.519 0.480 0.000
C02.3 Anterior two-thirds of tongue, part unspecified
0.519 0.480 0.000
C02.0 Dorsal surface of tongue
0.519 0.480 0.000
C25.7 Other parts of pancreas
0.519 0.481 0.000
C77.9 Lymph node, unspecified
0.518 0.482 0.000
R90.0 Intracranial space-occupying lesion
0.518 0.482 0.000
R47-R49 Symptoms and signs involving speech and voice
0.516 0.484 0.000
D09.1 Other and unspecified urinary organs
0.515 0.485 0.000
C48.2 Peritoneum, unspecified
0.513 0.487 0.000
C15.4 Middle third of oesophagus
0.512 0.487 0.000
N43.3 Hydrocele, unspecified
0.511 0.489 0.000
C41.4 Pelvic bones, sacrum and coccyx
0.510 0.490 0.000
C01 Malignant neoplasm of base of tongue
0.510 0.490 0.000
C11 Malignant neoplasm of nasopharynx
0.509 0.491 0.000
D39 Neoplasm of uncertain or unknown behaviour of female genital organs
0.508 0.492 0.000
R84.7 Abnormal histological findings
0.508 0.492 0.000
N44 Torsion of testis
0.508 0.492 0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma
0.506 0.494 0.000
C24.1 Ampulla of Vater
0.506 0.494 0.000
D40.9 Male genital organ, unspecified
0.504 0.496 0.000
D40.7 Other male genital organs
0.504 0.496 0.000
N42.1 Congestion and haemorrhage of prostate
0.503 0.497 0.000
D43.0 Brain, supratentorial
0.502 0.498 0.000
Chapter VIII Diseases of the ear and mastoid process
0.502 0.498 0.000
R78.8 Finding of other specified substances, not normally found in blood
0.501 0.499 0.000
N34.3 Urethral syndrome, unspecified
0.501 0.499 0.000
R96 Other sudden death, cause unknown
0.499 0.501 0.000
R95 Sudden infant death syndrome
0.499 0.501 0.000
R99 Other ill-defined and unspecified causes of mortality
0.499 0.501 0.000
R98 Unattended death
0.499 0.501 0.000
C83.1 Small cleaved cell (diffuse)
0.498 0.502 0.000
D46.6 Myelodysplastic syndrome with isolated del(5q) chromosomal abnormality
0.498 0.502 0.000
D46.5 Refractory anaemia with multi-lineage dysplasia
0.498 0.502 0.000
D46.3 Refractory anaemia with excess of blasts with transformation
0.498 0.502 0.000
D46.1 Refractory anaemia with sideroblasts
0.498 0.502 0.000
D46.0 Refractory anaemia without sideroblasts, so stated
0.498 0.502 0.000
R83.9 Unspecified abnormal finding
0.498 0.502 0.000
R83.7 Abnormal histological findings
0.498 0.502 0.000
R83.6 Abnormal cytological findings
0.498 0.502 0.000
R83.5 Abnormal microbiological findings
0.498 0.502 0.000
R83.4 Abnormal immunological findings
0.498 0.502 0.000
R83.3 Abnormal level of substances chiefly nonmedicinal as to source
0.498 0.502 0.000
R83.2 Abnormal level of other drugs, medicaments and biological substances
0.498 0.502 0.000
R83.1 Abnormal level of hormones
0.498 0.502 0.000
R83.0 Abnormal level of enzymes
0.498 0.502 0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.497 0.503 0.000
Y00-Y09 Assault
0.497 0.503 0.000
R39.2 Extrarenal uraemia
0.497 0.503 0.000
R78.9 Finding of unspecified substance, not normally found in blood
0.496 0.503 0.000
R78.7 Finding of abnormal level of heavy metals in blood
0.496 0.503 0.000
R78.6 Finding of steroid agent in blood
0.496 0.503 0.000
R78.5 Finding of psychotropic drug in blood
0.496 0.503 0.000
R78.4 Finding of other drugs of addictive potential in blood
0.496 0.503 0.000
R78.3 Finding of hallucinogen in blood
0.496 0.503 0.000
R78.2 Finding of cocaine in blood
0.496 0.503 0.000
R78.1 Finding of opiate drug in blood
0.496 0.503 0.000
C24.8 Overlapping lesion of biliary tract
0.496 0.504 0.000
C14.8 Overlapping lesion of lip, oral cavity and pharynx
0.495 0.505 0.000
C14.2 Waldeyer's ring
0.495 0.505 0.000
R82 Other abnormal findings in urine
0.493 0.507 0.000
C91.9 Lymphoid leukaemia, unspecified
0.492 0.507 0.000
N34.2 Other urethritis
0.492 0.508 0.000
D38 Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs
0.492 0.508 0.000
C94.7 Other specified leukaemias
0.491 0.509 0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified
0.491 0.509 0.000
C94.5 Acute myelofibrosis
0.491 0.509 0.000
C94.4 Acute panmyelosis
0.491 0.509 0.000
C94.3 Mast cell leukaemia
0.491 0.509 0.000
C94.2 Acute megakaryoblastic leukaemia
0.491 0.509 0.000
C94.1 Chronic erythraemia
0.491 0.509 0.000
C94.0 Acute erythraemia and erythroleukaemia
0.491 0.509 0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified
0.491 0.509 0.000
C96.8 Histiocytic sarcoma
0.491 0.509 0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.491 0.509 0.000
C96.6 Unifocal Langerhans-cell histiocytosis
0.491 0.509 0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis
0.491 0.509 0.000
C96.4 Sarcoma of dendritic cells (accessory cells)
0.491 0.509 0.000
C96.3 True histiocytic lymphoma
0.491 0.509 0.000
C96.2 Malignant mast cell tumour
0.491 0.509 0.000
C96.1 Malignant histiocytosis
0.491 0.509 0.000
C96.0 Letterer-Siwe disease
0.491 0.509 0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism
0.490 0.510 0.000
C00.0 External upper lip
0.489 0.510 0.000
D03.2 Melanoma in situ of ear and external auricular canal
0.489 0.510 0.000
C73-C75 Malignant neoplasms of thyroid and other endocrine glands
0.488 0.512 0.000
N46 Male infertility
0.488 0.512 0.000
Y51 Drugs primarily affecting the autonomic nervous system
0.488 0.512 0.000
R78.0 Finding of alcohol in blood
0.487 0.513 0.000
N48 Other disorders of penis
0.487 0.513 0.000
R84.9 Unspecified abnormal finding
0.486 0.513 0.000
R84.8 Other abnormal findings
0.486 0.513 0.000
R84.4 Abnormal immunological findings
0.486 0.513 0.000
R84.3 Abnormal level of substances chiefly nonmedicinal as to source
0.486 0.513 0.000
R84.2 Abnormal level of other drugs, medicaments and biological substances
0.486 0.513 0.000
R84.1 Abnormal level of hormones
0.486 0.513 0.000
R84.0 Abnormal level of enzymes
0.486 0.513 0.000
D03.4 Melanoma in situ of scalp and neck
0.486 0.514 0.000
D06 Carcinoma in situ of cervix uteri
0.486 0.514 0.000
C24.9 Biliary tract, unspecified
0.485 0.515 0.000
C83.0 Small cell (diffuse)
0.484 0.516 0.000
C50.6 Axillary tail of breast
0.484 0.516 0.000
D02.0 Larynx
0.484 0.516 0.000
Y42.1 Thyroid hormones and substitutes
0.484 0.516 0.000
D41.1 Renal pelvis
0.482 0.518 0.000
C83.7 Burkitt's tumour
0.479 0.520 0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified
0.479 0.521 0.000
Y42.5 Other oestrogens and progestogens
0.478 0.522 0.000
R84.6 Abnormal cytological findings
0.478 0.522 0.000
Y57.9 Drug or medicament, unspecified
0.477 0.523 0.000
C79.3 Secondary malignant neoplasm of brain and cerebral meninges
0.474 0.526 0.000
N36.3 Prolapsed urethral mucosa
0.472 0.528 0.000
C25.2 Tail of pancreas
0.470 0.529 0.000
N45.0 Orchitis, epididymitis and epididymo-orchitis with abscess
0.470 0.530 0.000
R89.7 Abnormal histological findings
0.470 0.530 0.000
C76 Malignant neoplasm of other and ill-defined sites
0.469 0.530 0.000
D03.1 Melanoma in situ of eyelid, including canthus
0.467 0.533 0.000
H90-H95 Other disorders of ear
0.467 0.533 0.000
D41.4 Bladder
0.466 0.534 0.000
C15.5 Lower third of oesophagus
0.466 0.534 0.000
D46.4 Refractory anaemia, unspecified
0.466 0.534 0.000
V40-V49 Car occupant injured in transport accident
0.465 0.535 0.000
C40.0 Scapula and long bones of upper limb
0.465 0.535 0.000
D09.9 Carcinoma in situ, unspecified
0.465 0.535 0.000
D09.7 Carcinoma in situ of other specified sites
0.465 0.535 0.000
D09.3 Thyroid and other endocrine glands
0.465 0.535 0.000
D09.2 Eye
0.465 0.535 0.000
C10.9 Oropharynx, unspecified
0.464 0.536 0.000
W00-W19 Falls
0.464 0.536 0.000
Y57.8 Other drugs and medicaments
0.464 0.536 0.000
D43.2 Brain, unspecified
0.463 0.537 0.000
C25.9 Pancreas, unspecified
0.462 0.538 0.000
R86.8 Other abnormal findings
0.462 0.538 0.000
D02.4 Respiratory system, unspecified
0.460 0.540 0.000
D02.3 Other parts of respiratory system
0.460 0.540 0.000
D02.2 Bronchus and lung
0.460 0.540 0.000
D02.1 Trachea
0.460 0.540 0.000
U82-U85 Resistance to antimicrobial and antineoplastic drugs
0.460 0.540 0.000
C93.9 Monocytic leukaemia, unspecified
0.459 0.541 0.000
C93.7 Other monocytic leukaemia
0.459 0.541 0.000
C93.3 Juvenile myelomonocytic leukaemia
0.459 0.541 0.000
C93.2 Subacute monocytic leukaemia
0.459 0.541 0.000
C93.0 Acute monocytic leukaemia
0.459 0.541 0.000
R89.9 Unspecified abnormal finding
0.459 0.541 0.000
R89.8 Other abnormal findings
0.459 0.541 0.000
R89.6 Abnormal cytological findings
0.459 0.541 0.000
R89.5 Abnormal microbiological findings
0.459 0.541 0.000
R89.4 Abnormal immunological findings
0.459 0.541 0.000
R89.3 Abnormal level of substances chiefly nonmedicinal as to source
0.459 0.541 0.000
R89.2 Abnormal level of other drugs, medicaments and biological substances
0.459 0.541 0.000
R89.1 Abnormal level of hormones
0.459 0.541 0.000
R89.0 Abnormal level of enzymes
0.459 0.541 0.000
C64-C68 Malignant neoplasms of urinary tract
0.459 0.541 0.000
C03.1 Lower gum
0.458 0.542 0.000
C22.7 Other specified carcinomas of liver
0.458 0.542 0.000
C22.4 Other sarcomas of liver
0.458 0.542 0.000
C22.3 Angiosarcoma of liver
0.458 0.542 0.000
C22.2 Hepatoblastoma
0.458 0.542 0.000
R94.8 Abnormal results of function studies of other organs and systems
0.457 0.543 0.000
C79.2 Secondary malignant neoplasm of skin
0.457 0.543 0.000
Y04 Assault by bodily force
0.456 0.544 0.000
C48.0 Retroperitoneum
0.456 0.544 0.000
N34.1 Nonspecific urethritis
0.455 0.544 0.000
N34.0 Urethral abscess
0.455 0.544 0.000
C17.9 Small intestine, unspecified
0.455 0.545 0.000
R77.1 Abnormality of globulin
0.455 0.545 0.000
C22.1 Intrahepatic bile duct carcinoma
0.455 0.545 0.000
R30.1 Vesical tenesmus
0.454 0.546 0.000
D44 Neoplasm of uncertain or unknown behaviour of endocrine glands
0.454 0.546 0.000
C17.8 Overlapping lesion of small intestine
0.454 0.546 0.000
C17.3 Meckel's diverticulum
0.454 0.546 0.000
R26.1 Paralytic gait
0.454 0.546 0.000
R77.9 Abnormality of plasma protein, unspecified
0.453 0.547 0.000
Y42.2 Antithyroid drugs
0.453 0.547 0.000
C06.0 Cheek mucosa
0.453 0.547 0.000
D41.9 Urinary organ, unspecified
0.452 0.547 0.000
D41.7 Other urinary organs
0.452 0.547 0.000
D41.3 Urethra
0.452 0.547 0.000
C60-C63 Malignant neoplasms of male genital organs
0.452 0.548 0.000
C00.1 External lower lip
0.451 0.549 0.000
N48.2 Other inflammatory disorders of penis
0.450 0.550 0.000
R77.2 Abnormality of alphafetoprotein
0.449 0.551 0.000
R77.0 Abnormality of albumin
0.449 0.551 0.000
Chapter XVI Certain conditions originating in the perinatal period
0.449 0.551 0.000
R76.0 Raised antibody titer
0.449 0.551 0.000
R74.9 Abnormal level of unspecified serum enzyme
0.449 0.551 0.000
C00.9 Lip, unspecified
0.449 0.551 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2025 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.